化疗-话题@MedSci

#化疗#

19篇内容 | 5941人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2177591, encodeId=568b21e7591fb, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=08d5109310a8' target=_blank style='color:#2F92EE;'>#老年癌症患者#</a> <a href='/topic/show?id=73ba1093118f' target=_blank style='color:#2F92EE;'>#加巴喷丁类药物#</a> <a href='/topic/show?id=386d109312cf' target=_blank style='color:#2F92EE;'>#兴奋型谵妄#</a>, objectTitle=Anesthesia & Analgesia ：加巴喷丁类药物的使用与减少老年癌症患者化疗中兴奋型谵妄发生相关：一项日本全国性回顾性队列研究, objectType=article, longId=805985, objectId=4f278059850d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021960829_4754896.webp, objectUrl=/article/show_article.do?id=4f278059850d, replyNumber=0, likeNumber=115, createdTime=2023-12-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4f278059850d, moduleTitle=Anesthesia & Analgesia ：加巴喷丁类药物的使用与减少老年癌症患者化疗中兴奋型谵妄发生相关：一项日本全国性回顾性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f278059850d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2177167, encodeId=347721e716716, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=0650803e21a' target=_blank style='color:#2F92EE;'>#耐药#</a> <a href='/topic/show?id=5e2e4e08988' target=_blank style='color:#2F92EE;'>#小细胞肺癌#</a> <a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a>, objectTitle=大咖谈 | 2023年WCLC & ESMO小细胞肺癌治疗新进展, objectType=article, longId=806626, objectId=6b4580662609, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=6b4580662609, replyNumber=0, likeNumber=152, createdTime=2023-12-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6b4580662609, moduleTitle=大咖谈 | 2023年WCLC & ESMO小细胞肺癌治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b4580662609)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175976, encodeId=417c21e5976b2, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=04b5839e6a9' target=_blank style='color:#2F92EE;'>#胰腺癌#</a>, objectTitle=一切取决于基因，67岁晚期胰腺癌仅用GTX化疗方案长期生存！, objectType=article, longId=804062, objectId=7d1080406252, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=7d1080406252, replyNumber=0, likeNumber=123, createdTime=2023-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7d1080406252, moduleTitle=一切取决于基因，67岁晚期胰腺癌仅用GTX化疗方案长期生存！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d1080406252)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175872, encodeId=62e421e587202, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a> <a href='/topic/show?id=34b54848271' target=_blank style='color:#2F92EE;'>#帕博利珠单抗#</a>, objectTitle=2023 SABCS | 新辅助帕博利珠单抗联合化疗治疗改善早期高风险ER+/HER2-乳腺癌：Ⅲ期KEYNOTE-756研究, objectType=article, longId=805748, objectId=f299805e4814, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668017232524_4754896.png, objectUrl=/article/show_article.do?id=f299805e4814, replyNumber=0, likeNumber=92, createdTime=2023-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f299805e4814, moduleTitle=2023 SABCS | 新辅助帕博利珠单抗联合化疗治疗改善早期高风险ER+/HER2-乳腺癌：Ⅲ期KEYNOTE-756研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f299805e4814)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175130, encodeId=421121e51305b, content=<a href='/topic/show?id=33771982175' target=_blank style='color:#2F92EE;'>#三阴性乳腺癌#</a> <a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=7a0fe1289c2' target=_blank style='color:#2F92EE;'>#癌干细胞#</a>, objectTitle=JCI：靶向Na+/K+泵的药物可杀死乳腺癌干细胞，有望开发出新的乳腺癌药物, objectType=article, longId=805103, objectId=8e4f80510318, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/20231214/1702563473093_2185383.png, objectUrl=/article/show_article.do?id=8e4f80510318, replyNumber=0, likeNumber=65, createdTime=2023-12-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2174944, encodeId=bbaf21e494490, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=826a10860295' target=_blank style='color:#2F92EE;'>#晚期食管鳞状细胞癌#</a> <a href='/topic/show?id=55b410661257' target=_blank style='color:#2F92EE;'>#卡度尼利#</a>, objectTitle=陈小兵教授：免疫双抗卡度尼利联合化疗一线治疗晚期食管鳞状细胞癌（ESCC）的研究解读, objectType=article, longId=804858, objectId=804880485849, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-filling-form-U2MAYRK.jpg, objectUrl=/article/show_article.do?id=804880485849, replyNumber=0, likeNumber=161, createdTime=2023-12-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=804880485849, moduleTitle=陈小兵教授：免疫双抗卡度尼利联合化疗一线治疗晚期食管鳞状细胞癌（ESCC）的研究解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=804880485849)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2173245, encodeId=3aa921e32454a, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=0c8265e2b3' target=_blank style='color:#2F92EE;'>#EGFR-TKI#</a>, objectTitle=李茵茵教授：珠联璧合，EGFR-TKI联合化疗优化治疗新进展, objectType=article, longId=803713, objectId=8bee803e1357, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/nurse-writing-on-a-clipboard-in-the-hospital-PZ3P5XL.jpg, objectUrl=/article/show_article.do?id=8bee803e1357, replyNumber=0, likeNumber=198, createdTime=2023-12-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8bee803e1357, moduleTitle=李茵茵教授：珠联璧合，EGFR-TKI联合化疗优化治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bee803e1357)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2173316, encodeId=3ed621e3316bc, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=fc5b108298c5' target=_blank style='color:#2F92EE;'>#胆道恶性肿瘤#</a> <a href='/topic/show?id=2abd10829951' target=_blank style='color:#2F92EE;'>#PD-1免疫检查点抑制剂#</a>, objectTitle=Lancet：化疗+免疫是晚期胆道恶性肿瘤一线治疗新标准, objectType=article, longId=803951, objectId=01c480395140, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301012/1697151909871_4754896.jpeg, objectUrl=/article/show_article.do?id=01c480395140, replyNumber=0, likeNumber=108, createdTime=2023-12-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=01c480395140, moduleTitle=Lancet：化疗+免疫是晚期胆道恶性肿瘤一线治疗新标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01c480395140)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2170900, encodeId=885021e090058, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=daf52906537' target=_blank style='color:#2F92EE;'>#免疫治疗#</a> <a href='/topic/show?id=d2ba5e382ac' target=_blank style='color:#2F92EE;'>#放射治疗#</a>, objectTitle=晚期肺癌还有治吗？, objectType=article, longId=802029, objectId=fa3480202934, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867513815_4754896.png, objectUrl=/article/show_article.do?id=fa3480202934, replyNumber=0, likeNumber=130, createdTime=2023-11-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fa3480202934, moduleTitle=晚期肺癌还有治吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa3480202934)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2170463, encodeId=ef9721e046384, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=7b2910612398' target=_blank style='color:#2F92EE;'>#度伐利尤单抗#</a> <a href='/topic/show?id=be5510e738c0' target=_blank style='color:#2F92EE;'>#曲美木单抗#</a> <a href='/topic/show?id=62e510e7391a' target=_blank style='color:#2F92EE;'>#RAS突变型转移性结直肠癌#</a>, objectTitle=读书报告 | MEDITREME研究：度伐利尤联合曲美木和化疗一线治疗RAS突变型转移性结直肠癌, objectType=article, longId=801916, objectId=58dc8019162b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=58dc8019162b, replyNumber=0, likeNumber=136, createdTime=2023-11-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=58dc8019162b, moduleTitle=读书报告 | MEDITREME研究：度伐利尤联合曲美木和化疗一线治疗RAS突变型转移性结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58dc8019162b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2169301, encodeId=3f682169301bb, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a> <a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a> <a href='/topic/show?id=0c8265e2b3' target=_blank style='color:#2F92EE;'>#EGFR-TKI#</a>, objectTitle=学术交流｜李茵茵教授：珠联璧合，EGFR-TKI联合化疗优化治疗新进展, objectType=article, longId=801317, objectId=689280131e09, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=689280131e09, replyNumber=0, likeNumber=136, createdTime=2023-11-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=689280131e09, moduleTitle=学术交流｜李茵茵教授：珠联璧合，EGFR-TKI联合化疗优化治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=689280131e09)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2129770, encodeId=aeb42129e703e, content=<a href='/topic/show?id=ed3e10610883' target=_blank style='color:#2F92EE;'>#地尔硫卓#</a>和<a href='/topic/show?id=d7dd62295e4' target=_blank style='color:#2F92EE;'>#格列本脲#</a>靶向<a href='/topic/show?id=7d2f1061092a' target=_blank style='color:#2F92EE;'>#尿激酶受体#</a>，抑制体内<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>的生长和转移，如果是靶向尿激酶受体，可能的作用是减少转移。从某种角度上看，尿激酶受体的激活，有助于微循环。但是，如果抑制了尿激酶受体，可能是短暂抑制了转移，但是从肿瘤本身而言，不一定是有益于治疗的。另外，影响尿激酶受体，可能会改变<a href='/topic/show?id=f0838291817' target=_blank style='color:#2F92EE;'>#肿瘤微环境#</a>，有助于<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>药物和<a href='/topic/show?id=a07f82814ec' target=_blank style='color:#2F92EE;'>#肿瘤免疫治疗#</a>药物进入肿瘤内部，提高疗效，这是值得研究的。还有，可能会减少<a href='/topic/show?id=390810611044' target=_blank style='color:#2F92EE;'>#肿瘤细胞簇#</a>的形成，这是肿瘤转移的必要条件，以前发现<a href='/topic/show?id=74b24141445' target=_blank style='color:#2F92EE;'>#地高辛#</a>有这样的作用。, objectTitle=JMC封面：福州大学徐芃/李金宇/黄明东等发现2款老药可以靶向尿激酶受体，具有抗肿瘤新用途, objectType=article, longId=769833, objectId=1832e698332c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230425/75e7b6514a2a4bbf89029ca18560f940.jpg, objectUrl=/article/show_article.do?id=1832e698332c, replyNumber=0, likeNumber=162, createdTime=2023-05-03, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1832e698332c, moduleTitle=JMC封面：福州大学徐芃/李金宇/黄明东等发现2款老药可以靶向尿激酶受体，具有抗肿瘤新用途, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1832e698332c)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2090569, encodeId=4f0320905696e, content=<a href='/topic/show?id=c1bb368266b' target=_blank style='color:#2F92EE;'>#卵巢上皮性癌#</a>一线<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>中国专家共识，<a href='/topic/show?id=08f236865a8' target=_blank style='color:#2F92EE;'>#卵巢癌#</a>, objectTitle=卵巢上皮性癌一线化疗中国专家共识, objectType=guider, longId=19573, objectId=2be571c002693a12, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=2be571c002693a12, replyNumber=0, likeNumber=167, createdTime=2022-09-27, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2be571c002693a12, moduleTitle=卵巢上皮性癌一线化疗中国专家共识, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=2be571c002693a12)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1247369, encodeId=52e8124e369ec, content=<a href='/topic/show?id=d8dbe130197' target=_blank style='color:#2F92EE;'>#癌症#</a><a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>, objectTitle=癌症化疗副作用不可怕，另类“神药”来帮忙！, objectType=article, longId=737963, objectId=5a49e37963f1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220901/e4789350c3b84320b53949d759bc5619.jpg, objectUrl=/article/show_article.do?id=5a49e37963f1, replyNumber=0, likeNumber=156, createdTime=2022-09-06, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a49e37963f1, moduleTitle=癌症化疗副作用不可怕，另类“神药”来帮忙！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a49e37963f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241512, encodeId=abb51241512d7, content=<a href='/topic/show?id=a07f82814ec' target=_blank style='color:#2F92EE;'>#肿瘤免疫治疗#</a>与<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>结合，有协同作用, objectTitle=惊艳亮相！NADIM II：新辅助化免联合为可切除IIIA/B期NSCLC带来生存获益！| WCLC 2022速递, objectType=article, longId=735666, objectId=d837e3566673, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220811/1660205004308_5490734.png, objectUrl=/article/show_article.do?id=d837e3566673, replyNumber=0, likeNumber=152, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d837e3566673, moduleTitle=惊艳亮相！NADIM II：新辅助化免联合为可切除IIIA/B期NSCLC带来生存获益！| WCLC 2022速递, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d837e3566673)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1232927, encodeId=485e123292e24, content=<a href='/topic/show?id=9efb80281aa' target=_blank style='color:#2F92EE;'>#老药新用#</a><a href='/topic/show?id=cf6a2584521' target=_blank style='color:#2F92EE;'>#伟哥#</a><a href='/topic/show?id=0a1b904e96c' target=_blank style='color:#2F92EE;'>#西地那非#</a><a href='/topic/show?id=ccf410109188' target=_blank style='color:#2F92EE;'>#食管癌#</a><a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a><a href='/topic/show?id=5d644229ec8' target=_blank style='color:#2F92EE;'>#增敏#</a>做个标记, objectTitle=Cell Rep Med：老药伟哥能增强食道癌化疗的效果？, objectType=article, longId=732636, objectId=c52fe32636ea, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220623/d432bfdfda0449509cc37123587d553b.jpg, objectUrl=/article/show_article.do?id=c52fe32636ea, replyNumber=0, likeNumber=258, createdTime=2022-07-17, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c52fe32636ea, moduleTitle=Cell Rep Med：老药伟哥能增强食道癌化疗的效果？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c52fe32636ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1218137, encodeId=35a1121813e8a, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a><a href='/topic/show?id=2493130e1a1' target=_blank style='color:#2F92EE;'>#NSCLC#</a>, objectTitle=Thorac Cancer：晚期NSCLC奥希替尼治疗进展后化疗联合免疫治疗优于单纯化疗, objectType=article, longId=293503, objectId=164d293503c3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202215/1641387286236_1611618.jpeg, objectUrl=/article/show_article.do?id=164d293503c3, replyNumber=0, likeNumber=159, createdTime=2022-05-09, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=164d293503c3, moduleTitle=Thorac Cancer：晚期NSCLC奥希替尼治疗进展后化疗联合免疫治疗优于单纯化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=164d293503c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1218136, encodeId=40a51218136eb, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>, objectTitle=化疗方案缩写搞不清？一文盘点肺癌、乳腺癌、结直肠癌、胃癌经典化疗方案, objectType=article, longId=723683, objectId=9070e2368305, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220408/1649389093141_2570354.jpg, objectUrl=/article/show_article.do?id=9070e2368305, replyNumber=0, likeNumber=141, createdTime=2022-05-09, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9070e2368305, moduleTitle=化疗方案缩写搞不清？一文盘点肺癌、乳腺癌、结直肠癌、胃癌经典化疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9070e2368305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1218135, encodeId=6d15121813529, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a><a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#结直肠癌#</a>, objectTitle=JAMA Oncol：局部晚期结直肠癌的全新辅助疗法——放化疗+诱导/巩固化疗！, objectType=article, longId=221421, objectId=c3fc22142171, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021121/1638368595383_2110107.JPG, objectUrl=/article/show_article.do?id=c3fc22142171, replyNumber=0, likeNumber=163, createdTime=2022-05-09, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3fc22142171, moduleTitle=JAMA Oncol：局部晚期结直肠癌的全新辅助疗法——放化疗+诱导/巩固化疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3fc22142171)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1218134, encodeId=0f171218134f0, content=<a href='/topic/show?id=adf23354483' target=_blank style='color:#2F92EE;'>#化疗#</a>, objectTitle=化疗药给药顺序分不清？一文搞懂20种常见化疗方案先后顺序, objectType=article, longId=724161, objectId=8446e24161bf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220412/1649764700728_5486984.png, objectUrl=/article/show_article.do?id=8446e24161bf, replyNumber=0, likeNumber=160, createdTime=2022-05-09, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8446e24161bf, moduleTitle=化疗药给药顺序分不清？一文搞懂20种常见化疗方案先后顺序, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8446e24161bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

化疗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #老年癌症患者# #加巴喷丁类药物# #兴奋型谵妄#

Anesthesia & Analgesia ：加巴喷丁类药物的使用与减少老年癌症患者化疗中兴奋型谵妄发生相关：一项日本全国性回顾性队列研究

2023-12-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #耐药# #小细胞肺癌# #免疫治疗#

大咖谈 | 2023年WCLC & ESMO小细胞肺癌治疗新进展

2023-12-25发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #胰腺癌#

一切取决于基因，67岁晚期胰腺癌仅用GTX化疗方案长期生存！

2023-12-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #乳腺癌# #帕博利珠单抗#

2023 SABCS | 新辅助帕博利珠单抗联合化疗治疗改善早期高风险ER+/HER2-乳腺癌：Ⅲ期KEYNOTE-756研究

2023-12-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#三阴性乳腺癌# #化疗# #癌干细胞#

2023-12-15发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #晚期食管鳞状细胞癌# #卡度尼利#

陈小兵教授：免疫双抗卡度尼利联合化疗一线治疗晚期食管鳞状细胞癌（ESCC）的研究解读

2023-12-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #肺癌# #EGFR-TKI#

李茵茵教授：珠联璧合，EGFR-TKI联合化疗优化治疗新进展

2023-12-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #胆道恶性肿瘤# #PD-1免疫检查点抑制剂#

Lancet：化疗+免疫是晚期胆道恶性肿瘤一线治疗新标准

2023-12-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #肺癌# #免疫治疗# #放射治疗#

晚期肺癌还有治吗？

2023-11-25发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #度伐利尤单抗# #曲美木单抗# #RAS突变型转移性结直肠癌#

读书报告 | MEDITREME研究：度伐利尤联合曲美木和化疗一线治疗RAS突变型转移性结直肠癌

2023-11-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#化疗# #肺癌# #EGFR-TKI#

学术交流｜李茵茵教授：珠联璧合，EGFR-TKI联合化疗优化治疗新进展

2023-11-18发表于上海

侠胆医心 (审核中...)

前往app查看评论内容

全文收起 #地尔硫卓#和#格列本脲#靶向#尿激酶受体#，抑制体内#肿瘤#的生长和转移，如果是靶向尿激酶受体，可能的作用是减少转移。从某种角度上看，尿激酶受体的激活，有助于微循环。但是，如果抑制了尿激酶受体，可能是短暂抑制了转移，但是从肿瘤本身而言，不一定是有益于治疗的。另外，影响尿激酶受体，可能会改变#肿瘤微环境#，有助于#化疗#药物和#肿瘤免疫治疗#药物进入肿瘤内部，提高疗效，这是值得研究的。还有，可能会减少#肿瘤细胞簇#的形成，这是肿瘤转移的必要条件，以前发现#地高辛#有这样的作用。

JMC封面：福州大学徐芃/李金宇/黄明东等发现2款老药可以靶向尿激酶受体，具有抗肿瘤新用途

2023-05-03发表于上海

小小医者 (审核中...)

前往app查看评论内容

#卵巢上皮性癌#一线#化疗#中国专家共识，#卵巢癌#

卵巢上皮性癌一线化疗中国专家共识

2022-09-27

小小医者 (审核中...)

前往app查看评论内容

#癌症##化疗#

癌症化疗副作用不可怕，另类“神药”来帮忙！

2022-09-06

循证小兵 (审核中...)

前往app查看评论内容

#肿瘤免疫治疗#与#化疗#结合，有协同作用

惊艳亮相！NADIM II：新辅助化免联合为可切除IIIA/B期NSCLC带来生存获益！| WCLC 2022速递

2022-08-28

病毒猎手 (审核中...)

前往app查看评论内容

#老药新用##伟哥##西地那非##食管癌##化疗##增敏#做个标记

Cell Rep Med：老药伟哥能增强食道癌化疗的效果？

2022-07-17

病毒猎手 (审核中...)

前往app查看评论内容

#化疗##NSCLC#

Thorac Cancer：晚期NSCLC奥希替尼治疗进展后化疗联合免疫治疗优于单纯化疗

2022-05-09

病毒猎手 (审核中...)

前往app查看评论内容

#化疗#

化疗方案缩写搞不清？一文盘点肺癌、乳腺癌、结直肠癌、胃癌经典化疗方案

2022-05-09

病毒猎手 (审核中...)

前往app查看评论内容

#化疗##结直肠癌#

JAMA Oncol：局部晚期结直肠癌的全新辅助疗法——放化疗+诱导/巩固化疗！

2022-05-09

病毒猎手 (审核中...)

前往app查看评论内容

#化疗#

化疗药给药顺序分不清？一文搞懂20种常见化疗方案先后顺序

2022-05-09

科室
- - 订阅+
  - 更多科室
工具
服务